Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 23, 2016 08:00 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Piper Jaffray Annual Healthcare Conference

ATHLONE, Ireland, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
November 22, 2016 08:00 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc Announces Third Quarter 2016 Financial and Operating Results and Provides Corporate Update

ATHLONE, Ireland, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
November 15, 2016 08:30 ET | Source: Innocoll Holdings plc

Innocoll to Report Third Quarter 2016 Financial Results and Host Webcast and Conference Call on November 22, 2016

ATHLONE, Ireland, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
November 14, 2016 08:30 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Stifel 2016 Healthcare Conference

ATHLONE, Ireland, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
August 17, 2016 08:00 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc Announces Second Quarter 2016 Financial and Operating Results and Provides Corporate Update

ATHLONE, Ireland, Aug. 17, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
August 11, 2016 16:01 ET | Source: Innocoll Holdings plc

Innocoll to Report Second Quarter 2016 Financial Results and Host Webcast and Conference Call on August 17, 2016

ATHLONE, Ireland, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
July 06, 2016 09:00 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

ATHLONE, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
June 23, 2016 09:00 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc Announces the Completion of Enrollment in Two Pivotal Phase 3 Clinical Trials of COGENZIA for the Treatment of Diabetic Foot Infections

ATHLONE, Ireland, June 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
June 16, 2016 09:20 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference

ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
June 13, 2016 16:15 ET | Source: Innocoll Holdings plc

Innocoll Holdings plc Announces Proposed Public Offering of Ordinary Shares

ATHLONE, Ireland, June 13, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...